BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 18594509)

  • 1. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.
    Jia S; Liu Z; Zhang S; Liu P; Zhang L; Lee SH; Zhang J; Signoretti S; Loda M; Roberts TM; Zhao JJ
    Nature; 2008 Aug; 454(7205):776-9. PubMed ID: 18594509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN-deficient cancers depend on PIK3CB.
    Wee S; Wiederschain D; Maira SM; Loo A; Miller C; deBeaumont R; Stegmeier F; Yao YM; Lengauer C
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13057-62. PubMed ID: 18755892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor.
    Berenjeno IM; Guillermet-Guibert J; Pearce W; Gray A; Fleming S; Vanhaesebroeck B
    Biochem J; 2012 Feb; 442(1):151-9. PubMed ID: 22150431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A constitutively activated form of the p110beta isoform of PI3-kinase induces prostatic intraepithelial neoplasia in mice.
    Lee SH; Poulogiannis G; Pyne S; Jia S; Zou L; Signoretti S; Loda M; Cantley LC; Roberts TM
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11002-7. PubMed ID: 20534477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers.
    Wang Q; Liu P; Spangle JM; Von T; Roberts TM; Lin NU; Krop IE; Winer EP; Zhao JJ
    Oncogene; 2016 Jul; 35(27):3607-12. PubMed ID: 26500061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoinositide 3-kinases p110α and p110β have differential roles in insulin-like growth factor-1-mediated Akt phosphorylation and platelet priming.
    Blair TA; Moore SF; Williams CM; Poole AW; Vanhaesebroeck B; Hers I
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1681-8. PubMed ID: 24903091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation.
    Foukas LC; Claret M; Pearce W; Okkenhaug K; Meek S; Peskett E; Sancho S; Smith AJ; Withers DJ; Vanhaesebroeck B
    Nature; 2006 May; 441(7091):366-70. PubMed ID: 16625210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER
    Hosford SR; Dillon LM; Bouley SJ; Rosati R; Yang W; Chen VS; Demidenko E; Morra RP; Miller TW
    Clin Cancer Res; 2017 Jun; 23(11):2795-2805. PubMed ID: 27903677
    [No Abstract]   [Full Text] [Related]  

  • 9. The phosphatidylinositol 3-kinase (PI3K) isoform dependence of tumor formation is determined by the genetic mode of PI3K pathway activation rather than by tissue type.
    Utermark T; Schmit F; Lee SH; Gao X; Schaffhausen BS; Roberts TM
    J Virol; 2014 Sep; 88(18):10673-9. PubMed ID: 24991009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p110α and p110β isoforms of PI3K are involved in protection against H
    Singh P; Bano N; Hossain MM; Basit R; Dar MJ
    Breast Cancer; 2019 May; 26(3):378-385. PubMed ID: 30499025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both p110alpha and p110beta isoforms of phosphatidylinositol 3-OH-kinase are required for insulin signalling in the hypothalamus.
    Tups A; Anderson GM; Rizwan M; Augustine RA; Chaussade C; Shepherd PR; Grattan DR
    J Neuroendocrinol; 2010 Jun; 22(6):534-42. PubMed ID: 20236230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant Role of PI3K p110α over p110β in Insulin and β-Adrenergic Receptor Signalling.
    Zhang B; Luk C; Valadares J; Aronis C; Foukas LC
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling.
    Chaussade C; Rewcastle GW; Kendall JD; Denny WA; Cho K; Grønning LM; Chong ML; Anagnostou SH; Jackson SP; Daniele N; Shepherd PR
    Biochem J; 2007 Jun; 404(3):449-58. PubMed ID: 17362206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.
    Guillermet-Guibert J; Bjorklof K; Salpekar A; Gonella C; Ramadani F; Bilancio A; Meek S; Smith AJ; Okkenhaug K; Vanhaesebroeck B
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8292-7. PubMed ID: 18544649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rac1-mediated membrane raft localization of PI3K/p110β is required for its activation by GPCRs or PTEN loss.
    Cizmecioglu O; Ni J; Xie S; Zhao JJ; Roberts TM
    Elife; 2016 Oct; 5():. PubMed ID: 27700986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110β-deficient myoblasts is mediated by PI3K p110α and mTORC2.
    Matheny RW; Lynch CM; Leandry LA
    Growth Factors; 2012 Dec; 30(6):367-84. PubMed ID: 23137199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific roles of the p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic insulin signaling and metabolic regulation.
    Sopasakis VR; Liu P; Suzuki R; Kondo T; Winnay J; Tran TT; Asano T; Smyth G; Sajan MP; Farese RV; Kahn CR; Zhao JJ
    Cell Metab; 2010 Mar; 11(3):220-30. PubMed ID: 20197055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p110beta is up-regulated during differentiation of 3T3-L1 cells and contributes to the highly insulin-responsive glucose transport activity.
    Asano T; Kanda A; Katagiri H; Nawano M; Ogihara T; Inukai K; Anai M; Fukushima Y; Yazaki Y; Kikuchi M; Hooshmand-Rad R; Heldin CH; Oka Y; Funaki M
    J Biol Chem; 2000 Jun; 275(23):17671-6. PubMed ID: 10748220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K isoform dependence of PTEN-deficient tumors can be altered by the genetic context.
    Schmit F; Utermark T; Zhang S; Wang Q; Von T; Roberts TM; Zhao JJ
    Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6395-400. PubMed ID: 24737887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits.
    Jiang X; Chen S; Asara JM; Balk SP
    J Biol Chem; 2010 May; 285(20):14980-14989. PubMed ID: 20231295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.